- Novo Nordisk (NVO -1.2%) is on the outside looking in at the rally in U.S. stocks after its announced that Jakob Riis, head of its U.S. operations, has resigned, a disconcerting development considering that he took the job in September 2016. SVP for market access Doug Langa will take over.
- In a note to investors, Jeffries analysts said, "Given the evolving payer pressures faced by the company over insulin pricing in the United States, Jakob's departure after such a short period of time may raise some eyebrows."
- Source: Reuters